I'm LongbridgeAI, I can summarize articles.BioStem Technologies raised $3 million via private placement, issuing shares at $4.08 and warrants exercisable at $3.83. Proceeds support working capital. The company signed a Registration Rights Agreement to file resale registration within 30 days, enhancing investor liquidity.
BioStem Technologies raised approximately $3.0 million through a private placement with institutional investors, issuing 735,296 common shares at $4.08 per share and Series A and Series B warrants exercisable for up to 1,470,592 additional shares at $3.83. The placement closed on September 30, 2026, with proceeds earmarked for working capital and general corporate purposes. In a related move, the company executed a Registration Rights Agreement to file a resale registration within 30 days and target effectiveness within 45 days, or 75 days under a full SEC review, enhancing investor liquidity.
Agreement 1: BioStem Technologies Secures $3 Million Private Placement; Issues Stock at $4.08 and Warrants
- Agreement type: Securities Purchase Agreement for private placement of equity and warrants
- Counterparty: Certain institutional investors
- Signed / Effective: Sep 29 2026 / Sep 29 2026
- Reason: Raise working capital and general corporate funds
Agreement 2: BioStem Technologies Sets Investor Registration Timeline for Shares and Warrant Stock
- Agreement type: Registration Rights Agreement for resale of shares and warrant shares
- Counterparty: Certain institutional investors
- Signed / Effective: Sep 29 2026 / Sep 29 2026
- Reason: Provide resale liquidity for investors
Original SEC Filing: BioStem Technologies, Inc. [ BSEM ] - 8-K - Sep. 30, 2026